Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Enlivex Therapeutics LTD (ENLV)

CUSIP: M4130Y906 | Healthcare · Biotechnology | Micro Cap | 3 institutional holders

Quarters

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile